Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Total Debt (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Total Debt came in at $60.7 billion in Q2 2026, down 2.5% year-over-year from $62.3 billion in Q2 2025, and down 16.18% quarter-over-quarter from $72.4 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Total Debt (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Total Debt across 18 years of filings, most recently posting $60.7 billion for Q2 2026.

  • In Q2 2026, Total Debt fell 2.5% year-over-year to $60.7 billion; the TTM figure through Jun 2026 stood at $60.7 billion (down 2.5% YoY), while the FY2025 annual figure was $56.4 billion, up 27.19% from the prior year.
  • Total Debt came in at $60.7 billion for Q2 2026 at Johnson & Johnson, down from $72.4 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $72.4 billion in Q1 2026 to a low of $33.8 billion in Q4 2023.
  • Average Total Debt over 5 years is $49.9 billion, with a median of $51.3 billion recorded in 2024.
  • Year-over-year, Total Debt soared 89.31% in 2023 and slumped 40.49% in 2024.
  • Over 5 years, Total Debt stood at $36.5 billion in 2022, then dropped by 6.03% to $34.3 billion in 2023, then climbed by 29.53% to $44.4 billion in 2024, then rose by 27.19% to $56.4 billion in 2025, then climbed by 7.62% to $60.7 billion in 2026.
  • Per Business Quant data, the three most recent Total Debt figures were $60.7 billion in Q2 2026, $72.4 billion in Q1 2026, and $56.4 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 60.73 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 70.82 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 9.59 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 63.19 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 25.19 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 38.81 Mn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
10 Jazz Pharmaceuticals 16.02 Bn 14.40 Bn 1.09 Bn 5.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 60.73 Bn
Mar 29, 2026 72.45 Bn
Dec 28, 2025 56.43 Bn
Sep 28, 2025 52.18 Bn
Jun 29, 2025 62.29 Bn
Mar 30, 2025 66.15 Bn
Dec 29, 2024 44.37 Bn
Sep 29, 2024 40.21 Bn
Jun 30, 2024 51.35 Bn
Mar 31, 2024 42.18 Bn
Dec 31, 2023 34.25 Bn
Oct 1, 2023 33.79 Bn
Jul 2, 2023 57.30 Bn
Apr 2, 2023 70.89 Bn
Jan 1, 2023 53.95 Bn
Oct 2, 2022 36.45 Bn
Jul 3, 2022 36.90 Bn
Apr 3, 2022 37.45 Bn
Jan 2, 2022 39.65 Bn
Oct 3, 2021 37.73 Bn